NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, November 19th. Investors of record on Friday, December 6th will be paid a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date is Thursday, December 5th. View Baxter International's Dividend History.

Baxter International announced that its board has approved a stock buyback program on Tuesday, November 13th 2018, which permits the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 6.1% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. Baxter International's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.64 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Baxter International.

13 brokers have issued 12-month price objectives for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they anticipate Baxter International's share price to reach $90.08 in the next year. This suggests a possible upside of 8.3% from the stock's current price. View Analyst Price Targets for Baxter International.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News articles about BAX stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Baxter International earned a coverage optimism score of 1.5 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near term. View News Stories for Baxter International.

Baxter International saw a decline in short interest in October. As of October 31st, there was short interest totalling 5,490,000 shares, a decline of 16.9% from the September 30th total of 6,610,000 shares. Based on an average daily volume of 2,830,000 shares, the days-to-cover ratio is currently 1.9 days. Currently, 1.1% of the company's stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Endologix (ELGX), Honeywell International (HON), Verizon Communications (VZ), Pfizer (PFE), AT&T (T) and Micron Technology (MU).

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (4.74%), Third Point LLC (3.30%), Veritas Asset Management LLP (1.25%), California Public Employees Retirement System (0.74%), Voya Investment Management LLC (0.59%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Veritas Asset Management LLP, Man Group plc, State of New Jersey Common Pension Fund D, Voya Investment Management LLC, First Trust Advisors LP, Alberta Investment Management Corp and Stifel Financial Corp. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Kornitzer Capital Management Inc. KS, California Public Employees Retirement System, Teacher Retirement System of Texas, Squarepoint Ops LLC, Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue and Varma Mutual Pension Insurance Co. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $83.17.

Baxter International has a market capitalization of $42.46 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]